Skip to main content
Toggle navigation
Search
Home
Icon Legend
Food/Drinks Available
CE's Available
Reception
Pre-registration Required
Livestreaming
Recorded Session
PULMONARY
Home
PULMONARY
PULMONARY
Type here to filter the list
(112) Calprotectin predicts cystic fibrosis pulmonary exacerbations in equivocal cases
Favorite
(113) Development and Characterization of Pulmonary Disease in G551D Ferret Model on Chest CT Imaging
Favorite
(114) The Use of Daily Home Spirometry to Predict Clinical Outcomes in Persons with Cystic Fibrosis
Favorite
(115) Efficacy of home respiratory culture kits in cystic fibrosis patients
Favorite
(116) Associations between lung T1-MRI, chest CT, and multiple breath washout in young children with mild CF lung disease
Favorite
(117) IL-6 and SPLUNC1 Fluctuations as Sex-Specific Markers of Acute Cystic Fibrosis Exacerbation.
Favorite
(118) Antibiotic Regimen Changes During Pediatric Pulmonary Exacerbation Treatment
Favorite
(119) Pulmonary Exacerbation Antibiotic Treatment for Children with Cystic Fibrosis and Polymicrobial Infection
Favorite
(120) Sleep disturbances after initiation of elexacaftor/tezacaftor/ivacaftor
Favorite
(121) The evaluation of lung disease progression after the introduction of lumacaftor/ivacaftor in young children
Favorite
(122) Changes in the lung clearance index in individuals who are newborn screening positive for CF with an inconclusive diagnosis (CFSPID)
Favorite
(123) Clinical improvement 2 years after starting elexacaftor/tezacaftor/ivacaftor in patients with advanced lung disease
Favorite
(124) CF-FIT: Cystic Fibrosis Fitness During Inpatient Treatment
Favorite
(125) Assessing Real World Outcomes in Patients with Cystic Fibrosis treated with
Elexacaftor-Tezacaftor-Ivacafto
r using a Smartphone App
Favorite
(126) Change in Pulmonary Function after Introduction of Elexacaftor/tezacaftor/ivacaftor: Results from the National CF-cohort in Denmark
Favorite
(127) Exploring the Impact of Highly Effective Modulator Therapy on Sleep in Children with Cystic Fibrosis
Favorite
(128) Sex-based differences in cystic fibrosis pulmonary exacerbations: Sub-analysis of the STOP2 cohort
Favorite
(129) Patent Foramen Ovale and Oxygenation in Patients with Cystic Fibrosis
Favorite
(130) A Machine learning approach for estimating FEV
1
% in Cystic Fibrosis using CT-derived lung parenchymal biomarkers
Favorite
(131) Feasibility of telehealth spirometry for patients with cystic fibrosis in a regional setting
Favorite
(132) Respiratory Symptoms Changes During Menstrual Cycles in Women with Cystic Fibrosis
Favorite
(133) Significant Clinical Response to Elexacaftor-Tezacaftor-Ivacaftor (ELX/TEZ/IVA)
in Five CF Patients Carrying the Class II- N1303K Mutation
Favorite
(134) Effect of Hypertonic Saline Therapy on Lung Clearance Index in Preschool Children with Cystic Fibrosis
Favorite
(135) Electronic home monitoring of children with cystic fibrosis to detect and treat acute pulmonary exacerbations and its effect on 1-year FEV
1
loss
Favorite
(136) Long-term clinical impact using a virtual model of care in Cystic Fibrosis
Favorite
(137) Tobacco smoke exposure reduces the clinical efficacy of ivacaftor: Results from the
G551D
observational trial (GOAL)
Favorite
(138) Defining and identifying early-onset lung disease in cystic fibrosis with cumulative clinical characteristics in the first 3 years of life
Favorite
(139) Discovering Symptom Clustering Patters During a Pulmonary Exacerbation in People with Cystic Fibrosis
Favorite
(140) Lung Function and Airway Inflammatory Markers in Children with CFTR-Related Metabolic Syndrome
Favorite
(141) Oxygen Enhanced-MRI (OE-MRI) and Multiple breath washout +/- Short extension (MBW
ShX
) as novel functional assessments of CF lung health
Favorite
(142) The STOP PEDS Pilot Study of Oral Antibiotic Timing in Pediatric CF Pulmonary Exacerbations
Favorite
(695) Correcting legacy multiple breath nitrogen washout data (MBWN
2
) is not equivalent to collecting new data directly using the corrected software
Favorite
